What Is BioKier?BioKier is an early-stage medical food and pharmaceutical company developing new proprietary products for diabetes and related disorders. BioKier has identified a therapeutic opportunity and is developing a novel oral product for management and treatment for type 2 diabetes and related comorbidities. This product will potentially also have effects in metabolic syndrome and obesity.
BioKier's PartnersBioKier, Inc. has created a network of partnerships with experts in pharmaceutical development, medical treatment, business strategy, law, and laboratory services. This allows BioKier to utilize specialized guidance and advice at every step of the development process.
5th Annual World Congress of Food and Nutrition, Kaohsiung, Taiwan
Dr. George Szewczyk, presented at the 5th Annual World Congress of Food and Nutrition, held November 18-20, 2016, at The Conference Venue – Kaohsiung Exhibition Center in Kaohsiung, Taiwan.
20th International Conference of Functional and Medical Foods for Chronic Diseases
First European patent granted for BioKier
BioKier has been informed by European Patent Office that the examining division intends to grant a European patent…